APA (7th ed.) Citation

S, K., A, P., KK, B., R, M., A, K., B, K., . . . SF, R. (2023). Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation disease. Genes & diseases, 11(1), 67. https://doi.org/10.1016/j.gendis.2023.02.045

Chicago Style (17th ed.) Citation

S, Kar, et al. "Identification of Galectin-3 as a Novel Potential Prognostic/predictive Biomarker and Therapeutic Target for Cerebral Cavernous Malformation Disease." Genes & Diseases 11, no. 1 (2023): 67. https://doi.org/10.1016/j.gendis.2023.02.045.

MLA (9th ed.) Citation

S, Kar, et al. "Identification of Galectin-3 as a Novel Potential Prognostic/predictive Biomarker and Therapeutic Target for Cerebral Cavernous Malformation Disease." Genes & Diseases, vol. 11, no. 1, 2023, p. 67, https://doi.org/10.1016/j.gendis.2023.02.045.